Viewpoint Molecular Targeting, LLC

Iowa City, IA 52246

SBIR Award Summary

Total Number of Awards 4
Total Value of Awards $797K
First Award Date 05/01/15
Most Recent Award Date 01/19/17

Key Personnel

Last Name Name Awards Contact
JOHNSON FRANCES L JOHNSON 3
SCHULTZ MICHAEL SCHULTZ 1

4 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-16-414
Budget: 01/19/17 - 06/30/17

? DESCRIPTION (provided by applicant): Melanoma the fastest growing cancer incidence in the world today and the American Cancer Society reports that death rates for melanoma continue to rise. Alarmingly, melanoma is the most common cancer in young adults under 30. One characteristic of metastatic melanoma cells that is recognized as a potent...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-071
Budget: 01/01/16 - 12/31/16

? DESCRIPTION (provided by applicant): Melanoma the fastest growing cancer incidence in the world today and the American Cancer Society reports that death rates for melanoma continue to rise. Alarmingly, melanoma is the most common cancer in young adults under 30. One characteristic of metastatic melanoma cells that is recognized as a potenti...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/22/15 - 06/21/16

Metastatic melanoma is almost uniformly fatal due to the development of resistance to all treatments. While recent FDA-approved drugs are achieving blockbuster status (e.g., Zelboraf), life expectancy is increased by just months and side effects are severe. While the commercial potential of radionuclide therapy is evidenced by recent introductio...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-071
Budget: 05/01/15 - 10/31/15

DESCRIPTION (provided by applicant): Melanoma incidence is growing faster than any other cancer and the American Cancer Society reports that death rates for melanoma have been rising in the United States for the past 30 years. Alarmingly, melanoma is the most common cancer in young adults under 30. One characteristic of metastatic melanoma cells...